Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study

Leonardo Tenori, Catherine Oakman, Patrick G. Morris, Ewa Gralka, Natalie Turner, Silvia Cappadona, Monica Fornier, Cliff Hudis, Larry Norton, Claudio Luchinat, Angelo Di Leo
  • Molecular Oncology, August 2014, Wiley
  • DOI: 10.1016/j.molonc.2014.07.012

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.molonc.2014.07.012

The following have contributed to this page: Professor Claudio Luchinat